Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry

Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential. Cases submitted to the Internatio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro-oncology (Charlottesville, Va.) Ročník 24; číslo 5; s. 821
Hlavní autoři: Lazow, Margot A, Fuller, Christine, DeWire, Mariko, Lane, Adam, Bandopadhayay, Pratiti, Bartels, Ute, Bouffet, Eric, Cheng, Sylvia, Cohen, Kenneth J, Cooney, Tabitha M, Coven, Scott L, Dholaria, Hetal, Diez, Blanca, Dorris, Kathleen, El-Ayadi, Moatasem, El-Sheikh, Ayman, Fisher, Paul G, Fonseca, Adriana, Garcia Lombardi, Mercedes, Greiner, Robert J, Goldman, Stewart, Gottardo, Nicholas, Gururangan, Sridharan, Hansford, Jordan R, Hassall, Tim, Hawkins, Cynthia, Kilburn, Lindsay, Koschmann, Carl, Leary, Sarah E, Ma, Jie, Minturn, Jane E, Monje-Deisseroth, Michelle, Packer, Roger, Samson, Yvan, Sandler, Eric S, Sevlever, Gustavo, Tinkle, Christopher L, Tsui, Karen, Wagner, Lars M, Zaghloul, Mohamed, Ziegler, David S, Chaney, Brooklyn, Black, Katie, Asher, Anthony, Drissi, Rachid, Fouladi, Maryam, Jones, Blaise V, Leach, James L
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 04.05.2022
Témata:
ISSN:1523-5866, 1523-5866
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential. Cases submitted to the International DIPG registry (IDIPGR) with histopathologic and/or radiologic data were analyzed. Central imaging review was performed on diagnostic brain MRIs (if available) by two neuro-radiologists. Imaging features suggestive of alternative diagnoses included nonpontine origin, <50% pontine involvement, focally exophytic morphology, sharply defined margins, and/or marked diffusion restriction throughout. Among 286 patients with pathology from biopsy and/or autopsy, 23 (8%) had histologic diagnoses inconsistent with DIPG, most commonly nondiffuse low-grade gliomas and embryonal tumors. Among 569 patients with centrally-reviewed diagnostic MRIs, 40 (7%) were classified as non-DIPG, alternative diagnosis suspected. The combined analysis included 151 patients with both histopathology and centrally-reviewed MRI. Of 77 patients with imaging classified as characteristic of DIPG, 76 (99%) had histopathologic diagnoses consistent with DIPG (infiltrating grade II-IV gliomas). Of 57 patients classified as likely DIPG with some unusual imaging features, 55 (96%) had histopathologic diagnoses consistent with DIPG. Of 17 patients with imaging features suggestive of an alternative diagnosis, eight (47%) had histopathologic diagnoses inconsistent with DIPG (remaining patients were excluded due to nonpontine tumor origin). Association between central neuro-imaging review impression and histopathology was significant (p < 0.001), and central neuro-imaging impression was prognostic of overall survival. The accuracy and important role of central neuro-imaging review in confirming the diagnosis of DIPG is demonstrated.
AbstractList Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential. Cases submitted to the International DIPG registry (IDIPGR) with histopathologic and/or radiologic data were analyzed. Central imaging review was performed on diagnostic brain MRIs (if available) by two neuro-radiologists. Imaging features suggestive of alternative diagnoses included nonpontine origin, <50% pontine involvement, focally exophytic morphology, sharply defined margins, and/or marked diffusion restriction throughout. Among 286 patients with pathology from biopsy and/or autopsy, 23 (8%) had histologic diagnoses inconsistent with DIPG, most commonly nondiffuse low-grade gliomas and embryonal tumors. Among 569 patients with centrally-reviewed diagnostic MRIs, 40 (7%) were classified as non-DIPG, alternative diagnosis suspected. The combined analysis included 151 patients with both histopathology and centrally-reviewed MRI. Of 77 patients with imaging classified as characteristic of DIPG, 76 (99%) had histopathologic diagnoses consistent with DIPG (infiltrating grade II-IV gliomas). Of 57 patients classified as likely DIPG with some unusual imaging features, 55 (96%) had histopathologic diagnoses consistent with DIPG. Of 17 patients with imaging features suggestive of an alternative diagnosis, eight (47%) had histopathologic diagnoses inconsistent with DIPG (remaining patients were excluded due to nonpontine tumor origin). Association between central neuro-imaging review impression and histopathology was significant (p < 0.001), and central neuro-imaging impression was prognostic of overall survival. The accuracy and important role of central neuro-imaging review in confirming the diagnosis of DIPG is demonstrated.
Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential.BACKGROUNDDiffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential.Cases submitted to the International DIPG registry (IDIPGR) with histopathologic and/or radiologic data were analyzed. Central imaging review was performed on diagnostic brain MRIs (if available) by two neuro-radiologists. Imaging features suggestive of alternative diagnoses included nonpontine origin, <50% pontine involvement, focally exophytic morphology, sharply defined margins, and/or marked diffusion restriction throughout.METHODSCases submitted to the International DIPG registry (IDIPGR) with histopathologic and/or radiologic data were analyzed. Central imaging review was performed on diagnostic brain MRIs (if available) by two neuro-radiologists. Imaging features suggestive of alternative diagnoses included nonpontine origin, <50% pontine involvement, focally exophytic morphology, sharply defined margins, and/or marked diffusion restriction throughout.Among 286 patients with pathology from biopsy and/or autopsy, 23 (8%) had histologic diagnoses inconsistent with DIPG, most commonly nondiffuse low-grade gliomas and embryonal tumors. Among 569 patients with centrally-reviewed diagnostic MRIs, 40 (7%) were classified as non-DIPG, alternative diagnosis suspected. The combined analysis included 151 patients with both histopathology and centrally-reviewed MRI. Of 77 patients with imaging classified as characteristic of DIPG, 76 (99%) had histopathologic diagnoses consistent with DIPG (infiltrating grade II-IV gliomas). Of 57 patients classified as likely DIPG with some unusual imaging features, 55 (96%) had histopathologic diagnoses consistent with DIPG. Of 17 patients with imaging features suggestive of an alternative diagnosis, eight (47%) had histopathologic diagnoses inconsistent with DIPG (remaining patients were excluded due to nonpontine tumor origin). Association between central neuro-imaging review impression and histopathology was significant (p < 0.001), and central neuro-imaging impression was prognostic of overall survival.RESULTSAmong 286 patients with pathology from biopsy and/or autopsy, 23 (8%) had histologic diagnoses inconsistent with DIPG, most commonly nondiffuse low-grade gliomas and embryonal tumors. Among 569 patients with centrally-reviewed diagnostic MRIs, 40 (7%) were classified as non-DIPG, alternative diagnosis suspected. The combined analysis included 151 patients with both histopathology and centrally-reviewed MRI. Of 77 patients with imaging classified as characteristic of DIPG, 76 (99%) had histopathologic diagnoses consistent with DIPG (infiltrating grade II-IV gliomas). Of 57 patients classified as likely DIPG with some unusual imaging features, 55 (96%) had histopathologic diagnoses consistent with DIPG. Of 17 patients with imaging features suggestive of an alternative diagnosis, eight (47%) had histopathologic diagnoses inconsistent with DIPG (remaining patients were excluded due to nonpontine tumor origin). Association between central neuro-imaging review impression and histopathology was significant (p < 0.001), and central neuro-imaging impression was prognostic of overall survival.The accuracy and important role of central neuro-imaging review in confirming the diagnosis of DIPG is demonstrated.CONCLUSIONSThe accuracy and important role of central neuro-imaging review in confirming the diagnosis of DIPG is demonstrated.
Author Samson, Yvan
Cohen, Kenneth J
Black, Katie
Bouffet, Eric
Diez, Blanca
Dorris, Kathleen
Lazow, Margot A
Kilburn, Lindsay
Koschmann, Carl
Tinkle, Christopher L
Dholaria, Hetal
Hansford, Jordan R
Fouladi, Maryam
Coven, Scott L
Cheng, Sylvia
Gururangan, Sridharan
El-Ayadi, Moatasem
Sevlever, Gustavo
Wagner, Lars M
Bartels, Ute
Zaghloul, Mohamed
DeWire, Mariko
Cooney, Tabitha M
Gottardo, Nicholas
Hawkins, Cynthia
Leary, Sarah E
Garcia Lombardi, Mercedes
Leach, James L
Lane, Adam
Minturn, Jane E
Hassall, Tim
Drissi, Rachid
Monje-Deisseroth, Michelle
Ziegler, David S
Chaney, Brooklyn
Asher, Anthony
Bandopadhayay, Pratiti
Fisher, Paul G
Jones, Blaise V
Fonseca, Adriana
Packer, Roger
Goldman, Stewart
Tsui, Karen
Fuller, Christine
Greiner, Robert J
El-Sheikh, Ayman
Sandler, Eric S
Ma, Jie
Author_xml – sequence: 1
  givenname: Margot A
  orcidid: 0000-0003-4362-4270
  surname: Lazow
  fullname: Lazow, Margot A
  organization: The Ohio State University College of Medicine, Columbus, Ohio, USA
– sequence: 2
  givenname: Christine
  orcidid: 0000-0001-7919-7675
  surname: Fuller
  fullname: Fuller, Christine
  organization: Department of Pathology, Upstate Medical University, Syracuse, New York, USA
– sequence: 3
  givenname: Mariko
  surname: DeWire
  fullname: DeWire, Mariko
  organization: Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
– sequence: 4
  givenname: Adam
  orcidid: 0000-0002-5522-8112
  surname: Lane
  fullname: Lane, Adam
  organization: Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
– sequence: 5
  givenname: Pratiti
  surname: Bandopadhayay
  fullname: Bandopadhayay, Pratiti
  organization: Dana Farber Cancer Institute, Harvard Cancer Center, Boston, Massachusetts, USA
– sequence: 6
  givenname: Ute
  orcidid: 0000-0003-2112-5251
  surname: Bartels
  fullname: Bartels, Ute
  organization: Division of Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
– sequence: 7
  givenname: Eric
  surname: Bouffet
  fullname: Bouffet, Eric
  organization: Division of Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
– sequence: 8
  givenname: Sylvia
  surname: Cheng
  fullname: Cheng, Sylvia
  organization: Division of Pediatric Hematology/Oncology/BMT, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 9
  givenname: Kenneth J
  surname: Cohen
  fullname: Cohen, Kenneth J
  organization: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
– sequence: 10
  givenname: Tabitha M
  surname: Cooney
  fullname: Cooney, Tabitha M
  organization: Dana Farber Cancer Institute, Harvard Cancer Center, Boston, Massachusetts, USA
– sequence: 11
  givenname: Scott L
  surname: Coven
  fullname: Coven, Scott L
  organization: Division of Oncology, Riley Hospital for Children, Indianapolis, Indiana, USA
– sequence: 12
  givenname: Hetal
  surname: Dholaria
  fullname: Dholaria, Hetal
  organization: Department of Oncology, Perth Children's Hospital, Nedlands, Australia
– sequence: 13
  givenname: Blanca
  surname: Diez
  fullname: Diez, Blanca
  organization: Department of Oncology and Pathology, Fundacion para la lucha de las enfermedades neurologicas de la infancia FLENI, Buenos Aires, Argentina
– sequence: 14
  givenname: Kathleen
  orcidid: 0000-0003-0753-2176
  surname: Dorris
  fullname: Dorris, Kathleen
  organization: Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA
– sequence: 15
  givenname: Moatasem
  surname: El-Ayadi
  fullname: El-Ayadi, Moatasem
  organization: National Cancer Institute, Cairo University and Children's Cancer Hospital Egypt, Cairo, Egypt
– sequence: 16
  givenname: Ayman
  surname: El-Sheikh
  fullname: El-Sheikh, Ayman
  organization: Division of Oncology, Dayton Children's Hospital, Dayton, Ohio, USA
– sequence: 17
  givenname: Paul G
  surname: Fisher
  fullname: Fisher, Paul G
  organization: Department of Neurology, Stanford University, Stanford, California, USA
– sequence: 18
  givenname: Adriana
  orcidid: 0000-0002-6382-6833
  surname: Fonseca
  fullname: Fonseca, Adriana
  organization: Division of Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
– sequence: 19
  givenname: Mercedes
  surname: Garcia Lombardi
  fullname: Garcia Lombardi, Mercedes
  organization: Division of Oncology, Hospital de Ninos Ricardo Gutierrez, Buenos Aires, Argentina
– sequence: 20
  givenname: Robert J
  surname: Greiner
  fullname: Greiner, Robert J
  organization: Division of Oncology, Penn State Health Children's Hospital, Hershey, Pennsylvania, USA
– sequence: 21
  givenname: Stewart
  surname: Goldman
  fullname: Goldman, Stewart
  organization: Department of Pediatrics, Phoenix Children's Hospital, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA
– sequence: 22
  givenname: Nicholas
  surname: Gottardo
  fullname: Gottardo, Nicholas
  organization: Department of Oncology, Perth Children's Hospital, Nedlands, Australia
– sequence: 23
  givenname: Sridharan
  orcidid: 0000-0003-0311-7127
  surname: Gururangan
  fullname: Gururangan, Sridharan
  organization: Department of Neurosurgery, University of Florida, Gainsville, Florida, USA
– sequence: 24
  givenname: Jordan R
  orcidid: 0000-0001-7733-383X
  surname: Hansford
  fullname: Hansford, Jordan R
  organization: Children's Cancer Centre, Royal Children's Hospital Murdoch Children's Research Institute University of Melbourne, Melbourne, Victoria, Australia
– sequence: 25
  givenname: Tim
  surname: Hassall
  fullname: Hassall, Tim
  organization: Division of Oncology, Queensland Children's Hospital, South Brisbane, Australia
– sequence: 26
  givenname: Cynthia
  surname: Hawkins
  fullname: Hawkins, Cynthia
  organization: Division of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada
– sequence: 27
  givenname: Lindsay
  surname: Kilburn
  fullname: Kilburn, Lindsay
  organization: Division of Oncology, Children's National Medical Center, Washinton, District of Columbia, USA
– sequence: 28
  givenname: Carl
  orcidid: 0000-0002-0825-7615
  surname: Koschmann
  fullname: Koschmann, Carl
  organization: Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA
– sequence: 29
  givenname: Sarah E
  surname: Leary
  fullname: Leary, Sarah E
  organization: Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA
– sequence: 30
  givenname: Jie
  surname: Ma
  fullname: Ma, Jie
  organization: Division of Oncology, Xinhua Hospital, Shanghai, China
– sequence: 31
  givenname: Jane E
  orcidid: 0000-0001-9069-8761
  surname: Minturn
  fullname: Minturn, Jane E
  organization: Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
– sequence: 32
  givenname: Michelle
  surname: Monje-Deisseroth
  fullname: Monje-Deisseroth, Michelle
  organization: Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
– sequence: 33
  givenname: Roger
  surname: Packer
  fullname: Packer, Roger
  organization: Division of Oncology, Children's National Medical Center, Washinton, District of Columbia, USA
– sequence: 34
  givenname: Yvan
  surname: Samson
  fullname: Samson, Yvan
  organization: Division of Oncology, CHU Saint Justine, Montreal, Quebec, Canada
– sequence: 35
  givenname: Eric S
  surname: Sandler
  fullname: Sandler, Eric S
  organization: Division of Oncology, Nemours Children's Health System, Wilmington, Delaware, USA
– sequence: 36
  givenname: Gustavo
  surname: Sevlever
  fullname: Sevlever, Gustavo
  organization: Department of Oncology and Pathology, Fundacion para la lucha de las enfermedades neurologicas de la infancia FLENI, Buenos Aires, Argentina
– sequence: 37
  givenname: Christopher L
  surname: Tinkle
  fullname: Tinkle, Christopher L
  organization: Division of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
– sequence: 38
  givenname: Karen
  surname: Tsui
  fullname: Tsui, Karen
  organization: Division of Oncology, Starship Children's Hospital, Auckland, New Zealand
– sequence: 39
  givenname: Lars M
  surname: Wagner
  fullname: Wagner, Lars M
  organization: Division of Pediatric Hematology/Oncology, University of Kentucky, Lexington, Kentucky, USA
– sequence: 40
  givenname: Mohamed
  surname: Zaghloul
  fullname: Zaghloul, Mohamed
  organization: National Cancer Institute, Cairo University and Children's Cancer Hospital Egypt, Cairo, Egypt
– sequence: 41
  givenname: David S
  surname: Ziegler
  fullname: Ziegler, David S
  organization: School of Women's and Children's Health and Children's Cancer Institute, University of New South Wales, Sydney, Australia
– sequence: 42
  givenname: Brooklyn
  surname: Chaney
  fullname: Chaney, Brooklyn
  organization: Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
– sequence: 43
  givenname: Katie
  orcidid: 0000-0002-3269-7303
  surname: Black
  fullname: Black, Katie
  organization: Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
– sequence: 44
  givenname: Anthony
  surname: Asher
  fullname: Asher, Anthony
  organization: Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
– sequence: 45
  givenname: Rachid
  orcidid: 0000-0003-0564-0181
  surname: Drissi
  fullname: Drissi, Rachid
  organization: Center for Childhood Cancer & Blood Disorders, Nationwide Children's Hospital, Columbus, Ohio, USA
– sequence: 46
  givenname: Maryam
  orcidid: 0000-0002-5693-035X
  surname: Fouladi
  fullname: Fouladi, Maryam
  organization: The Ohio State University College of Medicine, Columbus, Ohio, USA
– sequence: 47
  givenname: Blaise V
  orcidid: 0000-0001-9003-4578
  surname: Jones
  fullname: Jones, Blaise V
  organization: Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
– sequence: 48
  givenname: James L
  surname: Leach
  fullname: Leach, James L
  organization: Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34668975$$D View this record in MEDLINE/PubMed
BookMark eNpNkMtLxDAQh4OsuA-9epQcvdRN0qRJjsuq68KCInouaZo-pE1qmrr0v7e-wNMM8_vmg5klmFlnDQCXGN1gJOO1NYOzem2dyghlJ2CBGYkjJpJk9q-fg2XfvyFEMEvwGZjHNEmE5GwBuo3Wg1d6hK6A2tjgVQMnqXdR3aqytiX05qM2x6_8dv-0g9q1nfImh8c6VLCq--A6FSrXuHKEtYWhMnBvg_FWhdrZSfe99mzKCfXjOTgtVNObi9-6Aq_3dy_bh-jwuNtvN4dIU0JDVFAR64wrRGjCEFdCSJYjXiCS5IgpiQttqJTCaIZklk0DhqnkOedCZFIVZAWuf7ydd--D6UPa1r02TaOscUOfEiYowjwhaEKvftEha02edn463Y_p35fIJ76cbS8
CitedBy_id crossref_primary_10_3390_cancers16010219
crossref_primary_10_1002_pbc_29792
crossref_primary_10_1007_s00259_022_06105_z
crossref_primary_10_1016_j_radonc_2023_109789
crossref_primary_10_3390_cancers16081566
crossref_primary_10_1002_jrs_6637
crossref_primary_10_1002_pbc_30431
crossref_primary_10_1007_s00381_023_06037_5
crossref_primary_10_1007_s00381_024_06730_z
crossref_primary_10_1007_s10143_025_03788_4
ContentType Journal Article
Copyright The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/neuonc/noab245
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1523-5866
ExternalDocumentID 34668975
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: AHRQ HHS
  grantid: K12 HS026390
– fundername: NCI NIH HHS
  grantid: P30 CA124435
GroupedDBID ---
.2P
.I3
.XZ
.ZR
0R~
123
18M
2WC
36B
4.4
48X
53G
5VS
5WD
70D
AABZA
AACZT
AAJKP
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNHQ
ABNKS
ABPQP
ABPTD
ABQLI
ABQNK
ABVGC
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMMS
AHXPO
AIAGR
AIJHB
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
AOIJS
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EMB
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HYE
HZ~
IOX
J21
JXSIZ
KOP
KQ8
KSI
KSN
MHKGH
N9A
NGC
NOMLY
NOYVH
NPM
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
Q1.
Q5Y
RD5
ROX
RPM
RUSNO
RW1
RXO
SV3
TEORI
TJX
TR2
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
~91
7X8
AHGBF
AJBYB
KBUDW
ID FETCH-LOGICAL-c424t-f483cb7a0246507a8895d07f026d05a91fce4998ec509bba9151497d7788b9af2
IEDL.DBID 7X8
ISICitedReferencesCount 13
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000763961600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1523-5866
IngestDate Sat Sep 27 22:00:55 EDT 2025
Thu Apr 03 06:53:56 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords histopathology
non-DIPG
pontine tumor
DIPG
central imaging review
Language English
License The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c424t-f483cb7a0246507a8895d07f026d05a91fce4998ec509bba9151497d7788b9af2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5522-8112
0000-0003-0311-7127
0000-0003-4362-4270
0000-0002-6382-6833
0000-0003-2112-5251
0000-0001-7733-383X
0000-0002-0825-7615
0000-0003-0564-0181
0000-0003-0753-2176
0000-0001-9003-4578
0000-0001-9069-8761
0000-0002-5693-035X
0000-0002-3269-7303
0000-0001-7919-7675
OpenAccessLink https://academic.oup.com/neuro-oncology/article-pdf/24/5/821/43548803/noab245.pdf
PMID 34668975
PQID 2584017620
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2584017620
pubmed_primary_34668975
PublicationCentury 2000
PublicationDate 2022-05-04
PublicationDateYYYYMMDD 2022-05-04
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-04
  day: 04
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Neuro-oncology (Charlottesville, Va.)
PublicationTitleAlternate Neuro Oncol
PublicationYear 2022
SSID ssj0021561
Score 2.416446
Snippet Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 821
SubjectTerms Astrocytoma
Brain Stem Neoplasms - pathology
Glioma - diagnostic imaging
Glioma - pathology
Humans
Registries
Title Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry
URI https://www.ncbi.nlm.nih.gov/pubmed/34668975
https://www.proquest.com/docview/2584017620
Volume 24
WOSCitedRecordID wos000763961600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXEbyGpptks3uSolY9tBRR6G3JZhPpwWztQ_DfO8luKx4EwcsesgSWZDbzzTeT-RC6Upxqzo0mRlJDuLSCpEVbeSKfKlpIkcd5EJuQ_X4yHKaDmnCb1mWVizMxHNRFqT1H3orAU4L1xBG9Hr8Trxrls6u1hMYqajCAMr6kSw6XWQTwZnW_1IgRkcTxsmkjazkzL51uuVLlERe_w8vgZrrb__3AHbRVA0zcqSxiF60Yt4c2enUKfR-NO1rPJ0p_4tLiujQTh66WZPQWJItwdZ3Fv799HNzjRZk69pwtDg2KvY5x4OPxyGGAkPgHsVhNezKvQUnuAL10755vHkgtu0A0j_iMWJ4wnUsF3hvgm1RJkoqCSgvRWkGFSttWG4iTEqMBbOQ5DADoSmUhIZrOU2WjQ7TmSmeOEaZWmVjLtuFe6swyRVU7tbFmwkSi0KyJLhdrmYFZ-1yFcqacT7Pv1Wyio2pDsnHVfyNjPI6TVIqTP8w-RZuRv7DgSxT5GWpY-KnNOVrXH7PRdHIR7AWe_UHvC4wIzGQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Accuracy+of+central+neuro-imaging+review+of+DIPG+compared+with+histopathology+in+the+International+DIPG+Registry&rft.jtitle=Neuro-oncology+%28Charlottesville%2C+Va.%29&rft.au=Lazow%2C+Margot+A&rft.au=Fuller%2C+Christine&rft.au=DeWire%2C+Mariko&rft.au=Lane%2C+Adam&rft.date=2022-05-04&rft.eissn=1523-5866&rft.volume=24&rft.issue=5&rft.spage=821&rft_id=info:doi/10.1093%2Fneuonc%2Fnoab245&rft_id=info%3Apmid%2F34668975&rft_id=info%3Apmid%2F34668975&rft.externalDocID=34668975
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1523-5866&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1523-5866&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1523-5866&client=summon